Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Frontiers in Molecular Biosciences|December 5, 2022
Exogenous miRNAs from <i>Moringa oleifera</i> Lam. recover a dysregulated lipid metabolismValentina Roglia, Marina Potestà, Alessandra Minchella, et al.Plos One|December 7, 2013
Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)Paolo Palma, Maria Luisa Romiti, Carla Montesano, et al.Journal of Blood Medicine|February 23, 2023
Identification of Laboratory Biomarkers for Early Detection and Clinical Management of Post-Acute Syndrome Among Survivors of the 2013-2016 West Africa Ebola Outbreak in Sierra LeoneRaoul Emeric Guetiya Wadoum, Stephen Sevalie, Maurice Baimba Kargbo, et al.Vaccines|September 8, 2015
Immunotherapy with an HIV-DNA Vaccine in Children and AdultsPaolo Palma, Lindvi Gudmundsdotter, Andrea Finocchi, et al.Vaccine|January 11, 2011
The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected childrenPaolo Palma, Maria Luisa Romiti, Giuseppina Li Pira, et al.Journal of Public Health in Africa|January 29, 2019
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newbornsEdwige T Yelemkoure, Albert T Yonli, Carla Montesano, et al.Communications Biology|August 28, 2019
Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nutsKatia Aquilano, Veronica Ceci, Angelo Gismondi, et al.The Lancet. Infectious Diseases|March 4, 2017
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virusJudith R Glynn, Hilary Bower, Sembia Johnson, et al.Viruses|January 8, 2025
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income CountriesDavy-Hyacinthe Gouissi Anguechia, Yagai Bouba, Ezechiel Ngoufack Jagni Semengue, et al.Therapeutic Advances in Infectious Disease|April 28, 2025
HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocolVincent Kamaël Mekel, Ezechiel Ngoufack Jagni Semengue, Aude Christelle Ka'e, et al.Pageof 6